FDA Approves Drug to Treat Infants and Children with HIV
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four …
Read More